Select Your Time Zone  
8 May 2026
13:30-14:00
Session 1 - Opening Session
13:30-13:40
Welcome
Huri Özdoğan
13:40-14:00
FMF, Bird's Eye View
Ahmet Gül
14:00-16:00
Session 2
Chairs: İzzet Fresko, Ahmet Gül
14:00-14:30
Is Geography Destiny?
Nükhet Varlık
14:30-15:00
How to Study the Impact of Enviromental Factors on Disease Phenotype?
Thomas Henry
15:00-15:20
FMF in the Field
Huri Özdoğan
15:20-15:30
Q&A
15:30-15:40
Oral Presentation: Direct Ancient DNA Evidence of MEFV Variants in the Ancient City of Laodikeia, Western Anatolia
Selçuk Yüksel
15:40-16:10
Coffee Break
16:10-17:10
Session 3
Chairs: Gökhan Keser, Kenan Barut
16:10-16:40
Last 2 years review: Basic science
Yelda Bilginer
16:40-17:10
Last 2 years review: Clinical Science
Özgür Kasapçopur
17:10-17:55
Session 4
Chairs: Hasan Yazıcı, Melike Melikoğlu
17:10-17:25
Knowing What We Do Not Know
Hasan Yazıcı
17:25-17:55
Clinical Diagnosis Through the Brush of the Renaissance Painters and Beyond
Eldad Ben Chetrit (Online)
17:55-18:25
Project Discussion / Bosphorus Project
Project Working Group
9 May 2026
08:30-10:00
Session 5
Chairs: Seza Özen, Eda Tahir Turanlı
08:30-08:50
Pyrin Inflammasome Activation and Its Regulation
Mohamed Lamkanfi
08:50-09:00
Q&A
09:00-09:20
Challenges in Variant Interpretation and Speck-Seq Analysis
Thomas Henry
09:20-09:30
Q&A
09:30-09:50
Significance of Heterozygous Patients in FMF
Seza Özen
09:50-10:00
Q&A
10:00-10:30
Coffee Break
10:30-12:10
Session 6
Chairs: Thomas Henry, Cengiz Korkmaz, Fatoş Önen
10:30-10:50
FMF and Clonal Hematopoiesis
Sophie Georgin-Lavialle
10:50-10:55
Q&A
10:55-11:15
FMF as an Inflammatory Immune Dysregulation Disorder
Sulaiman Al-Mayouf
11:15-11:20
Q&A
11:20-11:40
The Smoldering Fire: Subclinical Inflammation
Helen Lachmann
11:40-12:00
Monitoring Inflammation: CRP and Beyond
Tilmann Kallinich
12:00-12:10
Q&A
12:10-12:40
Proceutica Satallite Symposium - Use of Kineret in Colchicine-Resistant Patients – Clinical Experience and Case Studies
Speaker: Abdurrahman Tufan Chairs: Ahmet Gül
12:40-13:30
Lunch & Poster Tour and Poster Reviewing
Chairs: Raffaele Manna, Erbil Ünsal, Isabelle Kone-Paut, Hakan Babaoğlu, Halide Özge Başaran, Piero Portincasa, Gizem Ayan, Mehmet Yıldız
13:30-14:20
Session 7
Chairs: Özgür Kasapçopur, Banu Balcı-Peynircioğlu
13:30-13:40
Autoinflammatory Diseases Involving the Pyrin Inflammasome
Ahmet Gül
13:50-13:55
Q&A
13:55-14:15
PFAPA, SURF and FMF
Marco Gattorno
14:15-14:20
Q&A
14:20-15:25
Session 8
Chairs: Helen Lachmann, Raffaele Manna, Erbil Ünsal
14:20-14:40
FMF in Isolated Populations
Piero Portincasa
14:40-14:55
Differential Diagnosis of FMF in FMF-Prevalent Regions
Abdurrahman Tufan
14:55-15:10
Differential Diagnosis of FMF in Low-Prevalence Regions
Charalampia Papadopoulou
15:10-15:25
Q&A
15:25-15:55
Coffee Break
16:00-17:00
Session 9
Chairs: Serdal Uğurlu, Charalampia Papadopoulou
16:00-16:20
Colchicine, Inflammation and Atherosclerosis: Is FMF an Exception Which Proves the Rule?
Eldad Ben-Chetrit (Online)
16:20-16:30
Q&A
16:30-16:50
Real life data: Anti–IL-1 Agents in FMF
Betül Sözeri
16:50-17:00
Q&A
17:00-17:45
Oral Presentations
Chairs: Yeşim Özgüler, Ezgi Özgün
17:00-17:45
Study of 34 prospective pregnancies in women receiving IL-1 inhibitors for systemic autoinflammatory diseases and comparison to unexposed pregnancies (GR2 study)
Marion Delplanque
17:00-17:45
Functional testing of primary monocytes can distinguish healthy controls from patients with cryopyrin associated periodic syndrome (CAPS) and familial mediterranean fever (FMF)
Megan Sallows
17:00-17:45
Familial Mediterranean Fever in Italy, Turkey, and Lebanon: a cross population analysis of genetics and clinical features.
Nour Jaber
17:00-17:45
Long-Term Outcomes of Living Related Kidney Donors to Recipients with AA Amyloidosis Due to Familial Mediterranean Fever
Özgur Akin Oto
17:45-18:35
Session 10
Chairs: Mikhail Kostik, Cemal Bes
17:45-18:05
Update: Treatment of AA Amyloidosis
Serdal Uğurlu
18:05-18:25
Management of Special Cases with Amyloidosis
Sophie Georgin-Lavialle
18:25-18:35
Q&A
10 May 2026
08:30-10:00
Session 11
Chairs: Marco Gattorno, Duygu Ersözlü
08:30-08:50
The Challenge to Treat FMF with Spondyloarthritis, PSA
Umut Kalyoncu
08:50-09:00
Q&A
09:00-09:20
Pros and Cons of Registries
Isabelle Kone Paut
09:20-09:30
Q&A
09:30-10:30
Oral Presentations
Chairs: Nihal Esatoğlu, Betül Sözeri, Gülay Özgön
09:30-10:30
IL-1 Inhibitor goflikicept in familial Mediterranean fever: results of the phase 2 international randomized trial.
Serdal Uğurlu
09:30-10:30
Definition of overlapping and mixed autoinflammatory disorders in patients carrying multiple autoinflammatory variants in a cohort of 483 patients followed at a tertiary referral centre.
Berşan Şen
09:30-10:30
Mortality in Familial Mediterranean Fever in the Contemporary Era: Comparison with the General Population and Independent Predictors of Survival
Ozgur Can Kilinc
09:30-10:30
Multi-omics profiling reveals selective CD16⁺ NK-cell collapse and TNF-driven apoptotic rewiring during Familial Mediterranean Fever flares
Zhicheng Zhou
09:30-10:30
Real-world effectiveness of IL-17 antagonists in familial Mediterranean fever–associated inflammatory conditions
Burak Karakaya
09:30-10:30
Investigating the cellular basis of colchicine resistance in FMF patients
Aysima Atilgan Lulecioglu
09:30-10:30
Completed suicide with colchicine in familial Mediterranean fever: demographic, clinical, and post-mortem features
Berkay Aktaş
09:30-10:30
Clinical Characteristics of Pediatric Patients with P369S/R408Q Mutation: A Single-Center Experience Across the FMF and PFAPA Spectrum
Atike Berra Mert
10:30-11:00
Coffee Break
11:00-12:10
Session 12
Chairs: Tilmann Kallinich, Levent Kılıç
11:00-11:30
Compliance and Transition
Ömer Karadağ / Amra Androvich
11:30-12:00
Treatment Cessation in Patients with FMF
Nuray Aktay Ayaz
12:00-12:10
Q&A
12:10-13:25
Session 13
Chairs: Huri Özdoğan, Ahmet Gül
12:10-12:25
Bosphorus Project
Project Working Group
12:25-12:40
Research Agenda in EULAR Recommendations
Erdal Sağ
12:40-13:00
Review of the Meeting
Sezgin Şahin
13:00-13:15
Abstract Awards
Serdal Uğurlu
13:15-13:30
Closing: Future Perspective
Huri Özdoğan, Ahmet Gül, Eldad Ben-Chetrit
13:30-14:30
LUNCH